Ameriflex Group Inc. Has $2.35 Million Stake in Procter & Gamble Company (The) $PG

Ameriflex Group Inc. boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 24.0% in the first quarter, HoldingsChannel reports. The firm owned 13,799 shares of the company’s stock after acquiring an additional 2,672 shares during the period. Procter & Gamble makes up 1.0% of Ameriflex Group Inc.’s portfolio, making the stock its 19th biggest position. Ameriflex Group Inc.’s holdings in Procter & Gamble were worth $2,352,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of PG. Nuveen LLC bought a new position in Procter & Gamble in the 1st quarter valued at $1,954,941,000. GAMMA Investing LLC boosted its position in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock valued at $1,355,087,000 after buying an additional 7,913,335 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its position in Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company’s stock valued at $2,728,430,000 after buying an additional 2,224,912 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Up 1.0%

NYSE:PG opened at $157.13 on Monday. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $368.07 billion, a P/E ratio of 24.14, a P/E/G ratio of 4.14 and a beta of 0.36. The stock’s fifty day simple moving average is $156.55 and its 200-day simple moving average is $162.44.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm’s revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.98%.

Analysts Set New Price Targets

PG has been the topic of a number of recent research reports. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an “equal weight” rating in a research report on Thursday, July 31st. Piper Sandler raised their price target on Procter & Gamble from $160.00 to $164.00 and gave the stock a “neutral” rating in a research report on Monday, May 5th. Finally, Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.12.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Sundar G. Raman sold 9,554 shares of Procter & Gamble stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,511,060.64. Following the sale, the chief executive officer owned 41,886 shares of the company’s stock, valued at $6,624,689.76. This trade represents a 18.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Susan Street Whaley sold 1,000 shares of Procter & Gamble stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the sale, the insider directly owned 28,436 shares in the company, valued at $4,459,902.24. This represents a 3.40% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.18% of the stock is currently owned by company insiders.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.